Factors Influencing Cancer Patients Participation in Clinical Trials in China.
Assessing Knowledge and Affecting Factors Associated With Cancer Patients Participation in Clinical Trials in China.
1 other identifier
observational
300
1 country
1
Brief Summary
This research studies factors affecting Chinese patient participation in cancer clinical trials and their knowledge regarding clinical trials. The investigators design this study to determining how patients makes decisions about participating in a clinical trial and know about patients' attitude toward clinical trials. The investigators aim to find ways to make cancer clinical trials in China more efficient and satisfied patients participating in clinical trials in China.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 15, 2017
CompletedFirst Submitted
Initial submission to the registry
December 29, 2017
CompletedFirst Posted
Study publicly available on registry
January 26, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedJanuary 26, 2018
January 1, 2018
1 year
December 29, 2017
January 20, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The patient related factors and the doctor related factors that influence patient decision regarding participation in a cancer clinical trial will be explored by questionnaire.
1 year
Secondary Outcomes (2)
Oncology patients' understanding and attitude of clinical trials towards cancer clinical research will be evaluated by questionnaire.
1 year
The actual experience of participants in a cancer clinical trial will be investigated by questionnaire.
1 year
Eligibility Criteria
Chinese patients with a diagnosis of cancer who have joined cancer clinical trial.
You may qualify if:
- Clinical diagnosis of malignancy
- Aged 18 years or older
- Ability to understand and complete the questionnaire independently or with the help of a relative or staff member of the oncology department
- Patients have been consented to join an oncology treatment clinical study and have begun active treatment of an oncology clinical trial
You may not qualify if:
- Not meeting all eligibility criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cancer Institute/Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Beijing, Beijing Municipality, 100021, China
Related Publications (1)
Jiang S, Liu P, Yang S, Yang J, Wu D, Fang H, Qin Y, Zhou S, Xu J, Sun Y, Mo H, Gui L, Xing P, Lan B, Zhang B, Tang L, Sun Y, Shi Y. Evaluating stress, satisfaction and the associated influencing factors of participants in cancer clinical trials: a cross-sectional study in China. BMJ Open. 2019 Jun 1;9(5):e028589. doi: 10.1136/bmjopen-2018-028589.
PMID: 31154312DERIVED
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Yuankai Shi, PhD
Chinese Academy of Medical Sciences
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of medical oncology Deputy Director National Cancer Center Vice President Cancer Hospital Chinese Academy of Medical Sciences(CAMS) & Peking Union Medical College(PUMC)
Study Record Dates
First Submitted
December 29, 2017
First Posted
January 26, 2018
Study Start
July 15, 2017
Primary Completion
August 1, 2018
Study Completion
December 1, 2018
Last Updated
January 26, 2018
Record last verified: 2018-01